主页 期刊库期刊详情
ISSN: 1083-4389 eISSN: 1523-5378 中科院分区: 医学(2区) No

HELICOBACTER

简称 HELICOBACTER ·UNITED STATES ·出版周期 Quarterly ·年均收录 74 篇
4.3
最新影响因子
11.40%
自引率
一般
投稿难度
平均2月
审稿周期
期刊简介

HELICOBACTER是一本专注于幽门螺杆菌及相关领域研究的国际学术期刊，其ISSN号为1083-4389，由美国出版商Wiley-Blackwell出版，出版地为美国，出版周期为双月刊。该期刊的影响因子根据年份有所不同，具体数值需查阅最新JCR报告，目前为非开放获取（非OA）期刊，被SCI收录，中科院分区需参考最新分区表（通常为医学或微生物学领域的3区或4区）。杂志的发文特点集中于幽门螺杆菌的病原学、流行病学、诊断治疗及与胃肠道疾病关联的研究，涵盖基础与临床医学的交叉领域。其质量较高，审稿严格，但作为细分领域期刊，受众相对局限，可能存在投稿竞争激烈或发表周期较长的风险，适合从事相关领域的研究者投稿。

影响因子趋势
近期发表
Population‐Level Trends in Gastric Cancer Mortality and Incidence After Expansion of Japanese National Health Insurance Coverage for <scp> <i>Helicobacter pylori</i> </scp> Eradication: A Descriptive Time‐Trend Study 2026-09-08
Issue Information 2026-09-08
A Novel <i>Helicobacter pylori</i> Test Based on 16S rRNA Isothermal Amplification Point‐of‐Care Testing of Throat Swab 2026-09-08
10.1111/hel.v31.5 2026-09-08
10.1111/hel.v31.4 2026-07-03
High Potency Proton Pump Inhibitor Versus Vonoprazan in <i>Helicobacter pylori</i> Triple Therapy 2026-07-22
Current Status of Diagnosis, Treatment, and Prevention of <i>Helicobacter pylori</i> Infection in China: A 2024–2025 National Multicenter Cross‐Sectional Study 2026-07-07
Antimicrobial Resistance Profile of <i>Helicobacter pylori</i> in Shenzhen, China: A Retrospective Study From 2021 to 2024 2026-08-01
Local Price and Clarithromycin Resistance Shape the Cost of Vonoprazan Triple Therapy for <i>Helicobacter pylori</i> Eradication 2026-08-20
Active <i>Helicobacter pylori</i> Infection and Survival Outcomes in De Novo Metastatic Colorectal Cancer: A Retrospective Cohort Study 2026-07-07
A Decade of Screening and Treating <scp> <i>Helicobacter pylori</i> </scp> Infection Among First‐Year High School Students in Kyoto, Japan: Annual Trends in Infection, Consultation, and Eradication Success Rates (2015–2023) 2026-08-16
School‐Based <i>Helicobacter pylori</i> Screening for Adolescents in Japan: Current Status, Challenges, and Implications: A Narrative Review 2026-08-16
Issue Information 2026-07-03
Worldwide Phylogenetic and Clinical Risk Association of the <scp> <i>Helicobacter pylori</i> </scp> Outer Membrane Gene <scp> <i>hopQ</i> </scp> 2026-07-03
Bismuth–Amoxicillin–Vonoprazan Triple, Amoxicillin–Vonoprazan Dual, and Clarithromycin‐Based Triple Therapies for First‐Line Treatment of <i>Helicobacter pylori</i> Infection: A Multicenter, Open‐Label, Randomized Trial 2026-08-25
14‐Day Vonoprazan–Minocycline Dual Therapy Versus Bismuth‐Containing Quadruple Therapy for <i>Helicobacter pylori</i> Rescue Treatment: A Single‐Center Randomized Controlled Noninferiority Trial 2026-08-20
Diagnostic Value of the Pylori DuoTect Test for <i>Helicobacter pylori</i> Detection in the Vietnamese Population 2026-08-11
Diagnostic Accuracy of Serum Antibody, Urine Antibody, and Stool Antigen Tests for <i>Helicobacter pylori</i> in Japan: A Systematic Review and Meta‐Analysis 2026-08-16
Evidence‐Based Guidelines for the Diagnosis and Treatment of <i>Helicobacter pylori</i> Infection in Korea: 2025 Revised Edition 2026-07-13
First Report of National Consensus Guidelines for the Diagnosis and Treatment of <i>Helicobacter pylori</i> Infection in Iran 2026-05-16
期刊信息
ISSN
1083-4389
期刊简称
HELICOBACTER
国家/地区
UNITED STATES
出版周期
Quarterly
中科院分区
医学(2区)
开放获取
No
研究领域
医学-微生物学
收录范围
Science Citation Index
详细类别
MICROBIOLOGY微生物学2区GASTROENTEROLOGY & HEPATOLOGY胃肠肝病学3区
投稿与主页
杂志主页
分析服务
分析服务

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话： 0531-88819269

微信公众号

关注微信订阅号，实时查看信息，关注医学生物学动态。


商务邮箱

E-mail: [email protected]

版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2